Studies utilising ASOs to manipulate GATA4 expression in cardiac hypertrophy suggest that ASOs act to enhance or reduce protein expression through their impact on RNA structure rather than specific interaction with the uORF start-site, suggesting that further experimentation to identify an appropriate ASO sequence combination to manipulate polycystin-1 expression could be successful [24]. The gene discussed is PKD1; the disease is cardiac hypertrophy.